Page 16 - Connectivity Platform News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Article content Study Stresses the Importance of Brain Monitoring During the Treatment of Patients with Severe COVID-19 NEUCHATEL, Switzerland — Masimo (NASDAQ: MASI) today announced the results of a prospective, observational study published in Critical Care in which researchers in Genoa, Italy, evaluated the impact of a variety of rescue therapies on the systemic and cerebral oxygenation of mechanically ventilated COVID-19 patients suffering from acute respiratory distress syndrome (ARDS). 1 To gauge the impact, the researchers used the Masimo Root ® Patient Monitoring and Connecti...

Masimo New Study Evaluates the Ability of Masimo EMMA® Capnography to Assess the Respiratory Status of Children With Tracheostomy Monday, March 15, 2021 1:12PM IST (7:42AM GMT)   Masimo (NASDAQ: MASI) today announced the findings of an observational, retrospective study published in Pediatrics International. In the study, researchers at the Osaka Women’s and Children’s Hospital in Japan found the Masimo EMMA ® Portable Capnograph “useful for assessment of the respiratory condition in children with tracheostomy.” 1 EMMA ® provides seamless mainstream capnography for patients of al...

Masimo (NASDAQ: MASI) today announced the findings of an observational, retrospective study published in Pediatrics International. In the study, researchers at the Osaka Women’s and Children’s Hospital in Japan found the Masimo EMMA ® Portable Capnograph “useful for assessment of the respiratory condition in children with tracheostomy.” 1 EMMA ® provides seamless mainstream capnography for patients of all ages in a compact, easily portable device. The device requires no routine calibration and minimal warm-up time, with accurate end-tidal carbon dioxide (EtCO 2) and respiration rat...

Press release content from Business Wire. The AP news staff was not involved in its creation. Masimo Monitoring Solutions Promote Newborn and Maternal Safety March 8, 2021 GMT Masimo Newborn Sensor (Photo: Masimo) NEUCHATEL, Switzerland--(BUSINESS WIRE)--Mar 8, 2021-- Masimo (NASDAQ: MASI) provides a variety of innovative monitoring solutions designed to improve maternal and newborn safety during childbirth and the critical first minutes of life. Masimo SET ® pulse oximetry’s ability to measure during motion and low perfusion has helped newborns, neonates, and pediatric patients like no ot...

Masimo Announces CE Marking of the Rad-G™ with Temperature Tuesday, March 2, 2021 1:26PM IST (7:56AM GMT)   Neuchatel, Switzerland:   Masimo (NASDAQ: MASI) today announced the CE marking of the Rad-G™ with Temperature, a rugged handheld device that provides clinically proven SET ® pulse oximetry, respiration rate from the pleth (RRp ®), and other important parameters alongside clinical-grade, non-contact infrared thermometry. With its long-lasting rechargeable battery, robust rubber casing, light weight, and integrated noninv...